Our Technology for Influenza

ENOB-FL-01: Aerosol/Inhaled Treatment Potentially for All Influenza Viruses


Hijack RNA Platform
Early Pre-Clinical

Influenza viruses are also RNA viruses. Therefore, a similar approach to Coronaviruses has been developed. The code targeted by the Hijack RNA is similar in all pandemic variants since 1918. In vitro experiments demonstrated rapid killing of infected cells without damage to uninfected cells.

Dr. Gumrukçu, co-founder and inventor of Enochian BioSciences, and Director of Seraph Research Institute, presented the initial findings at the 2020 Conference of the American Society of Gene and Cell Therapy (Find the Presentation Slides Here)

ENOB-FL-11: Aerosol/Inhaled Prophylaxis Potentially for All Influenza Viruses


Hijack RNA Platform
Early Pre-Clinical

The approach taken will be similar to that described for ENOB-CV-11 above.